Table 1.
Demographic Characteristics and Disposition of the 16 Study Subjects at Screening and Baseline
| All Subjects (n=16) | |
|---|---|
| Disposition of subjects | |
| Subjects randomized | 16 (100) |
| All subjects population | 16 (100) |
| PK population | 15 (94) |
| PD population | 16 (100) |
| Subjects completing the study | 15 (94) |
| Subjects withdrawn from the study | 1 (6) |
| Due to an adverse event | 1 (6) |
| Due to a serious adverse event | 0 |
| Demographics | |
| Age (yrs) | 30.4 ± 6.15 |
| Male sex | 15 (94) |
| BMI (kg/m2) | 22.04 ± 1.481 |
| Height (cm) | 169.8 ± 7.40 |
| Weight (kg) | 63.65 ± 7.238 |
| Asian or east Asian heritage | 16 (100) |
BMI = body mass index; PD = pharmacodynamics; PK = pharmacokinetics. Data are no. (%) of patients or mean ± SD values.